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Abstract
Objectives: The diagnostic values of the aVR lead or “Vereckei algorithm,” and the lead II R-wave peak
time (RWPT) criterion, recently devised for the differential diagnosis of wide QRS complex tachycardias
(WCTs), were compared.
Methods: A total of 212 WCTs (142 ventricular tachycardias [VTs], 62 supraventricular tachycardias
[SVT], and eight preexcitation SVTs) from 145 patients with proven electrophysiologic diagnoses were
retrospectively analyzed by seven examiners blinded to the electrophysiologic diagnoses.
Results: The overall test accuracy of the Vereckei algorithm was superior to that of the RWPT criterion
(84.3% vs. 79.6%; p = 0.0003). The sensitivity of the Vereckei algorithm for VT diagnosis was greater than
that of RWPT criterion (92.4% vs. 79.1%; p < 0.0001). The negative predictive value (NPV) for the
Vereckei algorithm was also greater (77.8%; 95% conﬁdence interval [CI] = 73.6% to 82.1%) than that of
the RWPT criterion (61.6%; 95% CI = 57.6% to 65.6%). The speciﬁcity of the Vereckei algorithm was
lower than that of the RWPT criterion (64.7% vs. 80.9%; p < 0.0001). The positive predictive value (PPV)
was also lower for the Vereckei algorithm (86.4%; 95% CI = 84.4% to 88.4%) than for the RWPT criterion
(90.9%; 95% CI = 89.1% to 92.8%). Incorrect diagnoses made by the Vereckei algorithm were mainly due
to misdiagnosis of SVT as VT (65.7% of cases), and those made by the RWPT criterion were due to the
more dangerous misdiagnosis of VT as SVT (72.5% of cases).
Conclusions: The Vereckei algorithm was superior in overall test accuracy, sensitivity, and NPV for VT
diagnosis and inferior in speciﬁcity and PPV to the RWPT criterion. All of these parameters were lower
in “real life” than those reported by the original authors for each of the particular electrocardiographic
methods.
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Elucidation of the mechanism of sustained, mono-morphic wide QRS complex tachycardia (WCT)is a common diagnostic dilemma for the emer-
gency physician. When confronted with the 12-lead
WCT electrocardiogram (ECG), a correct diagnosis is
vital not only for acute dysrhythmia treatment, but for
further prognosis and subsequent work-up, as well as
management. Because ventricular tachycardia (VT) and
supraventricular tachycardia (SVT) with aberrant intra-
ventricular conduction account for the vast majority of
WCTs (80 and 15% to 20%, respectively), the clinically
relevant problem is the distinction of VT from SVT with
aberrant intraventricular conduction (SVT-A) in the dif-
ferential diagnosis of WCTs. Other rare causes of WCT,
such as SVT with anterograde conduction over an
accessory pathway (preexcitation SVT), drug toxicity,
electrolyte disorders (hyperkalemia), ventricular paced
rhythm, or ECG artifact, account for only a small
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minority (1% to 5%) of WCTs.1–5 However, these num-
bers reﬂect the relative frequency of underlying causes
of WCT obtained from studies of consecutive patients
with WCT referred to electrophysiologic testing centers.
Thus, the great preponderance of VT as the underlying
cause of WCT might reﬂect the bias of difﬁcult cases
referred to electrophysiologic testing centers. Accord-
ing to some observations, the emergency physician
might encounter VT less frequently and more commonly
encounter other underlying causes of WCT in the emer-
gency department.6
The ECG remains the cornerstone of distinguishing
SVT-A from VT. Numerous ECG criterion and algo-
rithms have been published for the differential diagno-
sis of WCTs, including the landmark publications of
Sandler and Marriott,7 Swanick et al.,8 and Marriott
and Sandler,9 in 1965, 1966, and 1972; Wellens et al. in
197810; Coumel et al. in 198411; Kindwall et al. in 198812;
and Brugada et al. in 199113; as well as the most recent
publications of Vereckei et al.14,15 and Pava et al.16
Using all of these ECG methods, an accurate diagnosis
is now possible in about 90% of WCTs.17–19 A certain
ECG diagnosis of the WCT mechanism obviates the
need for a subsequent expensive and invasive electro-
physiologic study. However, overreliance on ECG algo-
rithms and criteria may be potentially dangerous,
because they still misdiagnose the underlying cause of
WCTs in up to 10% of cases. It seems prudent to con-
sider and treat all sustained, regular WCTs as VT unless
the diagnosis of SVT can be deﬁnitely established,
because it is far better to be wrong with a few cases of
SVT treated as VT than the reverse situation,1,14 since
treating a VT as SVT may result in potentially disastrous
consequences (e.g., intravenous [IV] verapamil injection
may cause severe hypotension and/or VT acceleration
and ventricular ﬁbrillation20,21). When ECG methods for
WCT differentiation were applied by physicians, the
reported diagnostic accuracy of a particular ECG
method is usually lower than that reported by the origi-
nal authors.22–27 Therefore, we sought to compare the
diagnostic value of two recently published simple ECG
methods, the aVR lead “Vereckei algorithm,”15 and the
lead II R-wave peak time (RWPT) criterion,16 for differ-
ential diagnosis of WCTs in “real life.”
Figure 1 shows the lead aVR Vereckei algorithm,
which contains two new criteria: 1) the vi/vt criterion
based on the estimation of initial (vi) and terminal (vt)
ventricular activation velocity ratio (vi/vt) and 2) the
presence of an initial R wave in lead aVR.
The rationale behind the vi/vt criterion is that during
WCT due to SVT, the initial activation of the septum
(occurring either left-to-right or right-to-left) should be
invariably rapid over the normal His-Purkinje system,
and the intraventicular conduction delay causing the
wide QRS complex occurs in the mid to terminal part of
the QRS, thus the vi/vt > 1 during SVT. During WCT
due to VT, however, an initial slower muscle-to-muscle
spread of activation occurs until the impulse reaches the
His-Purkinje system, after which the rest of the ventric-
ular muscle is more rapidly activated, thus, the vi/vt ≤ 1
during VT. This assumption should hold true regardless
of the mechanism of VT or presence or absence of
structural heart disease.
The presence of an initial R wave in lead aVR is
similar to the traditional northwest axis criterion,
which suggests VT, but is not the same, because the
range of the resultant QRS vector that yields an initial
R wave in lead aVR is between –60 and +120 degrees.
The initial ventricular activation wavefront during SVT
and sinus rhythm should go away from lead aVR,
yielding a negative QRS complex (an rS complex in
lead aVR may be present as a normal variant or in
patients with inferior myocardial infarction due to loss
of initial inferiorly directed forces, but with an R/S
ratio < 1). Thus, an initial dominant R wave (such as R
or Rs complex) in lead aVR should not be present in
SVT-A and suggests VT.
The principle on which the lead II RWPT criterion is
based is that most VTs (myocardial VTs) are associated
with slow initial ventricular activation close to the site
of origin due to slow muscle-to-muscle conduction,
resulting in a more signiﬁcantly prolonged QRS dura-
tion or time to the intrinsicoid deﬂection when the
mechanism of WCT is VT versus SVT.
Figure 1. The aVR Vereckei algorithm. SVT = supraventricular
tachycardia; VT = ventricular tachycardia.
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METHODS
Study Design
This was a retrospective cohort study, in which 12-lead
ECG tracings of WCTs from patients with proven elec-
trophysiologic diagnosis were analyzed by board-certi-
ﬁed cardiologists and emergency physicians as well as
internal medicine, emergency medicine, and cardiology
residents blinded to the electrophysiologic diagnoses
and the patients’ clinical data. The study complies with
the Declaration of Helsinki. An informed consent
exemption was obtained from the Indianapolis Univer-
sity Institutional Review Board for this analysis of a
deidentiﬁed data set.
Study Setting and Population
A subset of 12-lead ECGs (212 tracings out of the total
483 tracings) recorded from consecutive patients during
electrophysiologic studies conducted from June 1998 to
June 2005 at Indiana University (those with clearly
established electrophysiologic diagnoses) were evalu-
ated. The same recordings were used in our previous
studies.14,15 The 12-lead ECG printouts were sent to us
in series (series “A,” “B,” “C,” etc.) during the study and
we selected two series (series “B” and “C”) containing
sufﬁcient tracings (the chosen 212 tracings that were
recorded from consecutive patients) for this study. A
total of 212 regular WCT ECGs (142 VTs, 62 SVTs, and
eight preexcitation SVTs), recorded from 145 consecu-
tive patients out of the total 287 consecutive patients,
were retrospectively analyzed by seven observers
blinded to the electrophysiologic diagnoses and
patients’ clinical data.
Study Protocol
WCT was deﬁned as a rhythm with a rate of ≥100
beats/min and a QRS duration of ≥120 milliseconds.
Only regular, monomorphic WCTs were analyzed.
Despite the fact that preexcitation SVT is an SVT by
mechanism, preexcitation SVT behaves as a VT origi-
nating from the base of the ventricles both electrophysi-
ologically and regarding its ECG morphology. For this
reason, and because neither of the two ECG methods
used in this study, nor other ECG methods for WCT dif-
ferentiation, are able to differentiate preexcitation SVT
from VT unless atrioventricular dissociation is present,
when the mechanism of WCT was preexcitation SVT,
we considered a ﬁnal VT diagnosis correct and an SVT
diagnosis incorrect.15,28
The reviewers were given complete 12-lead standard
ECGs obtained during tachycardia for analysis. The
WCT ECG tracings were obtained from all kinds of
patients with and without structural heart disease, pre-
existent bundle branch block, or antiarrhythmic drug
treatment. Before examiners started to evaluate the
study ECGs, they all were provided with copies of the
published articles about the two ECG methods to be
used and received brief training on a different set of 30
ECGs to elucidate the potential pitfalls and caveats in
the application of the two ECG methods. The distribu-
tion of the seven examiners was the following: two
board-certiﬁed cardiologists, two board-certiﬁed emer-
gency physicians, one emergency medicine resident,
one internal medicine resident, and one cardiology
fellow who recently ﬁnished residency in internal med-
icine and started fellowship in cardiology.
The aVR Vereckei algorithm arrived at a diagnosis of
VT and the analysis was stopped if any of the following
criteria was met in lead aVR: 1) an initial R wave was
present, 2) the QRS started with an r or q wave of >40
millisecond width, or 3) there was a notch on the down-
sloping limb of a predominantly negative QRS with a
negative onset. When none of the ﬁrst three criteria
were met, in the fourth step we estimated the initial (vi)
and terminal (vt) ventricular activation velocity ratio (vi/
vt) by measuring the distance in mV the impulse trav-
eled vertically during the initial (vi) and terminal 40 mil-
liseconds (vt) of the QRS complex. In the fourth step,
when the vi/vt was ≤1 the diagnosis of VT was made
and if the vi/vt was >1 the diagnosis of SVT. Figures 2
and 3 show examples of how to apply the aVR Vereckei
algorithm. For more details see the original publica-
tion.15 The RWPT criterion suggested VT if the interval
from the QRS onset to the peak of the ﬁrst positive or
negative wave was ≥50 milliseconds in lead II, and it
suggested SVT if the interval was <50 milliseconds (see
Figures 4 and 5). For further details see the original
publication.16 The accurate determination of the onset
and end of the QRS complex is very important for the
proper application of the ECG methods. The onset and
end of the QRS were deﬁned by determination of the
earliest and latest ventricular depolarization, respec-
tively, in the three simultaneously recorded limb leads
(aVR, aVL, aVF; or I, II, III).
Data Analysis
Occurrence of true as well as false-positive and -negative
results, as well as sensitivity and speciﬁcity, were com-
pared between two ECG methods by ﬁrst constructing
2 9 2 tables demonstrating where the two ECG methods
agreed or disagreed. Thereafter, the nonparametric
McNemar’s test was used to compare two related pro-
portions, to determine which ECG method was better.
SPSS 13 for Windows software package (IBM SPSS,
Armonk, NY) was used for statistical analysis. A p < 0.05
value was considered statistically signiﬁcant. The type I
error rate was not adjusted for multiple testing of the
same variables. The above-described method was not
suitable for the comparison of the predictive values,
because the denominators for the two ECG methods dif-
fer (unlike speciﬁcity and sensitivity, in which the denom-
inators are the same). Lacking an entirely appropriate
statistical method to compare the predictive values, these
are presented simply with 95% conﬁdence intervals (CIs)
without statistical comparison. A signiﬁcant between-
groups difference in ECG methods is suggested by
disjoint (nonoverlapping) CIs. Some patients are in the
data set more than once (several VTs with different mor-
phology were induced in some patients, while a few had
WCTs due to both SVT and VT during the same electro-
physiologic study). Because these episodes behaved as
independent, unrelated events, they were analyzed as
different WCT tracings in the study.
The kappa statistic was performed to determine
interobserver agreement using the SAS statistical soft-
ware package (SAS Software Release 6.12, SAS Institute
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Inc., Cary, NC). Overall interobserver agreement was
deﬁned as near complete if j > 0.8, good if j = 0.61 to
0.8, moderate if j = 0.41 to 0.6, fair if j = 0.21 to 0.4,
and poor if j < 0.2.29
RESULTS
Patient Characteristics
The patients were younger in the preexcitation SVT and
SVT groups than in the VT group, and far more patients
had structural heart disease and histories of prior myo-
cardial infarction or cardiomyopathy in the VT group
than in the preexcitation SVT and SVT groups (see
Table 1). No patient in the preexcitation SVT group and
fewer patients in the SVT group took antiarrhythmic
drugs than in the VT group. There were more females
in the SVT group than in the two other groups, and
20% to 30% of the baseline ECG tracings showed pre-
existing bundle branch block in both the SVT and VT
groups.
Overall Test Accuracy
The results are shown in Table 2. The seven examiners
together correctly classiﬁed 1,251 of 1,484 (84.3%) WCT
tracings using the aVR Vereckei algorithm and 1,182
out of 1,484 (79.6%) WCT tracings with the lead II
RWPT criterion. The mean overall test accuracy of the
aVR Vereckei algorithm was superior to that of the lead
II RWPT criterion (p = 0.0003). In a post hoc analysis,
the seven observers were divided into subgroups of
experienced observers (four board-certiﬁed physicians)
and inexperienced observers (three residents). The
experienced observers achieved a signiﬁcantly better
mean overall test accuracy with the aVR Vereckei algo-
rithm than with the lead II RWPT criterion (738 of 848,
or 86.6% vs. 671 of 848, or 79.1%; p < 0.001), while the
inexperienced observers obtained similar mean overall
test accuracy with the two ECG methods (517 of 636, or
81.3% vs. 511 of 636, 80.3%, p = 0.68). The mean overall
test accuracy obtained by the seven observers with the
aVR Vereckei algorithm was lower in the current study
than in the original article (84.3% vs. 90.3%). Overall
test accuracy was not published for the lead II RWPT
criterion in the original article.
The incorrect diagnoses (233 of 1,484; 15.7%) were
mostly due to SVTs misdiagnosed as VTs (153 of 233;
65.7%) by the seven observers together using the aVR
Vereckei algorithm. In contrast, the incorrect diagnoses
Figure 2. Examples for the positivity of the first three steps of the new aVR algorithm. The figure demonstrates three different wide
QRS tachycardia WCT ECGs where one of the first three steps of the new aVR algorithm was positive (i.e., suggested a diagnosis of
VT). Only the simultaneously recorded leads aVR, aVL, and aVF are shown from each 12-lead ECG. In the left panel an initial R-wave is
present in lead aVR; thus the first step suggests VT. The crossing point of the vertical line with the contour of the last QRS denotes the
onset of the QRS. In the middle panel an rS complex is seen in lead aVR, with an R-wave width of 70 milliseconds; therefore, the second
step of the algorithm suggests VT. The right panel displays a notch on the downstroke of a negative onset and predominantly negative
QRS; thus VT is diagnosed in the third step. The crossing points of the two vertical lines with the contour of the sixth QRS complex
mark the onset and end of the QRS. Reproduced, with permission, from Vereckei A, Duray G, Szenasi G, Altemose GT, Miller JM. A
new algorithm using only lead aVR for the differential diagnosis of wide QRS complex tachycardia. Heart Rhythm 2008;5:89–98.15
ECG = electrocardiogram; SVT = supraventricular tachycardia; VT = ventricular tachycardia; WCT = wide QRS complex tachycardia.
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Figure 3. The use of vi/vt criterion in the fourth step of the new aVR algorithm. In both panels the crossing points of the vertical
lines with the QRS contour in lead aVR show the onset and end of the QRS complex in lead aVR. The crossing points and initial
and terminal 40 milliseconds of the chosen QRS complex are marked by small crosses. In the left panel, during the initial 40 milli-
seconds of the QRS the impulse traveled vertically 0.15 mV; therefore, the vi = 0.15 and during the terminal 40 milliseconds of the
QRS the impulse traveled vertically 0.6 mV; therefore, the vt = 0.6, and thus the vi/vt < 1 yields a diagnosis of VT. In the right panel
the vi = 0.4 and vt = 0.2 determined the same way as in the left panel, and thus vi/vt > 1 suggests a diagnosis of SVT. Reproduced,
with permission, from Vereckei A, Duray G, Szenasi G, Altemose GT, Miller JM. A new algorithm using only lead aVR for the differ-
ential diagnosis of wide QRS complex tachycardia. Heart Rhythm 2008;5:89–98.15 VT = ventricular tachycardia; SVT = supraventricu-
lar tachycardia; WCT = wide QRS complex tachycardia.
Figure 4. The use of the lead II RWPT criterion. (A) Twelve-lead WCT tracing recorded from a patient with SVT and a right bundle
branch block pattern. (B) Magnified view of lead II from A. The RWPT, which is the interval between the two vertical arrows, was
<50 milliseconds; thus SVT diagnosis was made with the lead II RWPT criterion. RWPT = R-wave peak time; SVT = supraventricular
tachycardia; WCT = wide QRS complex tachycardia.
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(302 of 1,484; 20.4%) were mostly due to VTs misdiag-
nosed as SVTs (219 of 302; 72.5%) by the seven observ-
ers together using the lead II RWPT criterion, which is
the more dangerous type of misclassiﬁcation. The diag-
nosis was established in the ﬁrst step in approximately
25% of the cases and in the fourth step in 50% to 60%
of WCTs using the aVR Vereckei algorithm, although
there was some variation among the observers.
Sensitivity, Speciﬁcity, and Predictive Values
Table 3 demonstrates the sensitivity, speciﬁcity, and
predictive values of the two ECG methods. Because only
two ﬁnal diagnoses (VT or SVT) were possible with the
ECG methods used, the speciﬁcity and positive predic-
tive value (PPV) for VT diagnosis were the same as the
sensitivity and negative predictive value (NPV) for SVT
diagnosis (respectively), and inversely, the sensitivity
and NPV for VT diagnosis were the same as the speci-
ﬁcity and PPV for SVT diagnosis (respectively). For this
reason only data for VT diagnosis are reported, which
can be applied accordingly for the appropriate parame-
ters in SVT diagnosis (Table 3). The seven observers
together, as well as the experienced and inexperienced
observers subgroups, achieved signiﬁcantly superior
sensitivity and inferior speciﬁcity for VT diagnosis using
the aVR Vereckei algorithm compared with the lead II
RWPT criterion.
The mean PPV for VT diagnosis reached by the seven
observers together was signiﬁcantly greater for the lead
II RWPT criterion than that for the aVR Vereckei algo-
rithm. However, there was no difference in the PPVs for
the lead II RWPT criterion compared with that for the
aVR Vereckei algorithm in the experienced or in the
Figure 5. The use of the lead II RWPT criterion. (A) Twelve-lead WCT tracing recorded from a patient with VT and left bundle
branch block pattern. (B) Magnified view of lead II from A. The RWPT, which is the interval between the two vertical arrows, was
≥50 milliseconds; thus VT diagnosis was made with the lead II RWPT criterion. RWPT = R-wave peak time; VT = ventricular tachy-
cardia; WCT = wide QRS complex tachycardia.
Table 1
Clinical Characteristics
Characteristic SVT VT
Preexcitation
SVT
WCT ECG tracings, n 62 142 8
Patients, n 58 79 8
Age (yr), mean (SD) 44 (19) 54 (18) 39 (21)
Female/male 25/33 14/65 1/7
Antiarrhythmic drugs,%* 5 44 0
Preexisting bundle branch
block†
29 25 0
Past history*
Post MI,% 2 44 0
Cardiomyopathy,% 3 15 0
No structural heart
disease,%
91 39 100
*% of patient n.
†% of WCT ECG tracings n.
ECG = electrocardiogram; MI = myocardial infarction;
SVT = supraventricular tachycardia; VT = ventricular tachy-
cardia; WCT = wide QRS complex tachycardia.
Table 2
The Percentage of Correct Diagnoses (Overall Test Accuracy)
Made Using the Two ECG Reading Methods
ECG Method Correct Diagnosis 95% CI
aVR Vereckei algorithm
Seven readers 1,251/1,484 (84.3%)* 82.0–86.0
Four experienced readers 738/848 (86.6%)* 84.4–88.7
Three inexperienced
readers
517/636 (81.3%) 78.9–83.7
RWPT criterion
Seven readers 1,182/1,484 (79.6%) 77.2–82.1
Four experienced readers 671/848 (79.1%) 76.6–81.6
Three inexperienced
readers
511/636 (80.3%) 77.9–82.8
The numbers represent number of correct diagnoses/total
number of tracings investigated with the ECG method (per-
centage = test accuracy). The overall (for both VT and SVT
diagnosis test accuracy of the two ECG methods were com-
pared statistically.
*p < 0.001 vs. the RWPT criterion evaluated by the same
number of observers.
RWPT = lead II R-wave peak time criterion; SVT = supraven-
tricular tachycardia; VT = ventricular tachycardia.
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inexperienced observers subgroups. The aVR Vereckei
algorithm had a greater mean NPV for VT diagnosis in
the hands of the seven observers together and of the
experienced observers subgroup compared with that
for the lead II RWPT criterion (Table 3).
The sensitivity, speciﬁcity, and predictive values for
VT diagnosis of the seven observers together using
either ECG method were lower than those reported in
the original publications (sensitivity 92.4% vs. 96.5%,
speciﬁcity 64.7% vs. 75%, PPV 86.4% vs. 92.7%, NPV
77.8% vs. 86.6% for the aVR Vereckei algorithm; sensi-
tivity 79.1% vs. 93.2%, speciﬁcity 80.9% vs. 99.3%, PPV
90.9% vs. 98.2%, NPV 61.6% vs. 93.3% for the lead II
RWPT criterion).
The mean kappa value of the seven observers
together suggested a moderate interobserver agreement
for both ECG methods (j = 0.49, 95% CI = 0.46 to 0.52
for the aVR Vereckei algorithm; j = 0.60, 95% CI = 0.57
to 0.63 for the lead II RWPT criterion). However, the in-
terobserver agreement of the experienced observers
was good, far superior to the fair to moderate agree-
ment of the inexperienced observers for both ECG
methods (j = 0.73, 95% CI = 0.67 to 0.78 vs. j = 0.27,
95% CI = 0.19 to 0.35 for the aVR Vereckei algorithm;
j = 0.73, 95% CI = 0.67 to 0.78 vs. j = 0.46, 95%
CI = 0.38 to 0.54 for the lead II RWPT criterion).
DISCUSSION
Main Findings
The mean overall test accuracy of the aVR Vereckei
algorithm achieved by all seven observers was superior
to that of the lead II RWPT criterion, which was mainly
due to the better overall test accuracy achieved by the
experienced four observers. The aVR Vereckei algo-
rithm was superior in sensitivity and NPV and inferior
in speciﬁcity and PPV to the lead II RWPT criterion
when mean values of all seven observers were com-
pared. The incorrect diagnoses of the aVR Vereckei
algorithm were mainly due to misdiagnosis of SVT as
VT (in 65.7% of cases), and those of the lead II RWPT
criterion were mostly due to the potentially more dan-
gerous misdiagnosis of VT as SVT (in 72.5% of cases).
This study revealed the real-life diagnostic value of the
two ECG methods as we found lower overall test accu-
racy, sensitivity, speciﬁcity, and predictive values in the
current study than in the original publications for the
two ECG methods. It seems likely that in the hands of
experienced physicians, the four-step, but still simple,
aVR Vereckei algorithm has a greater diagnostic value
than the single-step, very simple lead II RWPT criterion.
However, both ECG methods have comparable diagnos-
tic value when used by inexperienced physicians. The
effect of experience on the results achieved is also
reﬂected in the far better interobserver agreement
among the experienced than among the inexperienced
observers. The results of this analysis should be inter-
preted with caution given its post hoc nature and the
small sample size.
The Potential Utility of the aVR Vereckei Algorithm
and Lead II RWPT Criterion in Real Life
These two ECG methods can be well applied in real life
in the stressful and urgent setting of a WCT, because
both are simple, use only one lead for analysis, and
eliminate the difﬁcult-to-recall morphologic criteria. In
the hands of experienced observers, the aVR Vereckei
algorithm proved to be superior to the lead II RWPT
criterion. When the two ECG methods were applied by
inexperienced physicians, the two ECG methods had
comparable diagnostic value.
Because the differential diagnosis of WCTs is a quite
complicated task requiring experience in cardiology, it
may be recommended for an inexperienced physician to
consult with a supervisor, if possible, and apply
together the simple and more accurate aVR Vereckei
algorithm. If there is no supervisor available for consul-
tation, the inexperienced physician alone can apply the
simpler lead II RWPT criterion at the expense of a
somewhat greater likelihood of misdiagnosis.
Head-to-head Comparison of Different ECG
Methods for WCT Differential Diagnosis by
Independent Authors
The only other study25 that compared the diagnostic
value of the aVR Vereckei algorithm and lead II RWPT
Table 3
Sensitivity, Specificity, and Predictive Values of the Two ECG Methods for VT Diagnosis
ECG Method Sensitivity Specificity PPV NPV
aVR Vereckei algorithm
Seven readers 92.4† (90.8–94) 64.7† (60.3–69.2) 86.4‡ (84.4–88.4) 77.8‡ (73.6–82.1)
Four experienced 93.0* (91.0–95.0) 71.0* (65.3–76.6) 88.6 (86.1–91.1) 80.7‡ (75.5–86)
Three inexperienced 91.6* (89.0–94.1) 56.5* (49.3–63.6) 83.6 (80.3–86.8) 73.4 (66.2–80.7)
RWPT criterion
Seven readers 79.1 (76.7–81.6) 80.9 (77.2–84.6) 90.9 (89.1–92.8) 61.6 (57.6–65.6)
Four experienced 76.3 (72.9–79.7) 85.9 (81.6–90.2) 92.9 (90.6–95.2) 60.0 (54.9–65.1)
Three inexperienced 82.9 (79.4–86.4) 74.2 (67.9–80.5) 88.6 (85.6–91.6) 64.2 (57.8–70.6)
Numbers represent percentage values; numbers in parentheses are 95% CI. A significant between ECG methods difference refer-
ring to the same number of observers in predictive values (‡) is indicated by disjoint (nonoverlapping) 95% CIs.
*p < 0.001 vs. that of the RWPT criterion evaluated by the same number of observers.
†p < 0.0001 vs. that of the RWPT criterion evaluated by the same number of observers.
RWPT = lead II R-wave peak time criterion; NPV = negative predictive value; PPV = positive predictive value; VT = ventricular
tachycardia.
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criterion compared ﬁve ECG methods for differentiation
of WCT (the lead II RWPT criterion, Brugada, Grifﬁth,30
Bayesian,31 and aVR Vereckei algorithms) and did not
ﬁnd any signiﬁcant differences between the diagnostic
accuracy of the ﬁve ECG methods, although the diag-
nostic accuracy of lead II RWPT criterion tended to be
slightly lower than that of the aVR Vereckei algorithm
(68.8% vs. 71.9%, respectively). Similar to our results,
they veriﬁed a superior speciﬁcity and inferior sensitiv-
ity for VT diagnosis of the lead II RWPT criterion com-
pared with those of the aVR Vereckei algorithm (82.7%
vs. 48% for speciﬁcity and 60% vs. 87.1% for sensitivity,
respectively) and failed to reproduce the high diagnostic
accuracy, sensitivity, and speciﬁcity reported for the
four algorithms and the lead II RWPT criterion in their
respective original publications. However, in a study by
Jastrzebski et al.,25 in contrast to our approach and the
recommendation of Brugada and coworkers32 and of
Fernando Pava (personal communication), when the
mechanism of WCT was preexcitation SVT and the ﬁnal
diagnosis by the applied aVR Vereckei, Brugada algo-
rithms, or lead II RWPT criterion was VT, they consid-
ered it as an incorrect diagnosis and the SVT diagnosis
as a correct one. This important discrepancy renders
difﬁcult the comparison of the results of the two studies.
However, the potential misclassiﬁcation of their 23 pre-
excitation SVTs out of the total 260 WCTs might not
have signiﬁcantly changed the conclusions of Jastrzeb-
ski et al.25 In a recent report, four emergency resident
reviewers analyzed WCT ECG tracings using the aVR
Vereckei algorithm.26 When two of the four reviewers
who left disproportionately high numbers of ECGs
unclassiﬁed at the ﬁnal step of the algorithm were elimi-
nated from the analysis, the two remaining reviewers
achieved a somewhat lower but similar overall test
accuracy (70 and 74%) to the mean overall test accuracy
of our three inexperienced observers (81.3%). In a pedi-
atric population, lower diagnostic accuracy for both the
Brugada and the aVR Vereckei algorithms (69% vs.
66%, respectively) has been reported with no difference
in the diagnostic accuracy between the two algo-
rithms.25
Practical Application of ECG Methods for WCT
Differentiation
Although we failed in real life to reproduce the high
overall test accuracy, sensitivity, speciﬁcity, and predic-
tive values reported by the original authors, the two
investigated ECG methods showed good-to-very good
overall test accuracies, sensitivities, and PPVs and fair-
to-good speciﬁcities and NPV values. Currently there is
no single and very simple ECG method available (and
very likely such a method will not be available in the
future) that is able to diagnose the mechanism of WCT
with a close to 100% diagnostic accuracy regardless of
the level of experience of the physician applying the
method. Thus, there is no simple ECG criterion that can
obviate the experience of the evaluating physician.
When confronted with a hemodynamically stable
WCT, a useful practical approach is to look for clinical
signs of AV dissociation (e.g., “cannon” A waves) and
assess the patient’s clinical characteristics. A history of
prior myocardial infarction, congestive heart failure,
and angina strongly suggests VT, while age < 35 years,
recurrent tachycardia over a period of more than
3 years, and absence of structural heart disease favor
SVT.2 One should evaluate the 12-lead WCT ECG for
the most speciﬁc criteria in a sequence of decreasing
speciﬁcity such as AV dissociation, <1:1 AV ratio, >1:1
VA ratio, northwest axis (between 180 and –90
degrees), initial R or Rs wave in lead aVR, absence of
RS complex in the precordial leads, and concordant pat-
tern in the precordial leads. The presence of any of the
above criteria strongly suggests VT. If our results are
conﬁrmed by other investigators, a lead II RWPT ≥ 50
milliseconds might be also used in the future to strongly
suggest VT. SVT diagnosis is highly likely if the mor-
phology of the WCT corresponds to any combination of
a typical bundle branch block or fascicular block and
the vi/vt ratio > 1. If the morphology of WCT deﬁnitely
does not correspond to any combination of typical bun-
dle branch block or fascicular block VT or preexcitation
SVT diagnosis is very likely, a vi/vt ≤ 1 strongly suggests
VT or preexcitation SVT as well.1 When a sinus rhythm
ECG is available and the QRS morphology in the sinus
rhythm ECG is identical to that of the WCT ECG, SVT
diagnosis (or rarely antidromic AV reentrant tachycar-
dia) is highly likely.1,33 However, bundle branch reentry
VT, fascicular VT, and high midseptal VT may be associ-
ated with identical QRS morphology during WCT to
that during sinus rhythm as well, and this way may
masquerade as SVT in patients with ﬁxed intraventricu-
lar conduction disturbances.34 Using the Valsalva
maneuver, carotid sinus massage, or adenosine admin-
istration may help elucidate the WCT mechanism. The
termination of tachycardia strongly suggests SVT; how-
ever, idiopathic outﬂow tract VT may be terminated as
well by these maneuvers. Even if the tachycardia itself
remains unaffected, these maneuvers may clarify the
WCT mechanism by inducing AV or VA block or slow-
ing down the sinus or atrial rate.2,3 When all these mea-
sures fail to establish a certain diagnosis of SVT, then
the WCT should be treated as a VT. One should keep in
mind that the differential diagnosis of regular mono-
morphic WCT is not absolutely necessary for acute
management, because it can be successfully treated with
electrical cardioversion regardless of the mechanism.
LIMITATIONS
Certain circumstances in this study might have inﬂu-
enced the results. The observers were blinded not only
to the electrophysiologic diagnosis, but also to the clini-
cal characteristics of the patients. The knowledge of
patients’ histories might have improved the results, and
would have better mimicked real life. On the other
hand, the short training the observers received before
starting the evaluation might have improved the results.
In contrast to some other studies13,16,30,31 from which
patients with antiarrhythmic drug treatment, idiopathic
VT, and either preexistent bundle branch block were
excluded or their presence was not speciﬁed, we chose
to include WCT tracings obtained from patients with
the above features in our study, which might have
decreased the diagnostic accuracy of the ECG methods
used.
1128 Szelenyi et al. • TWO NEW ECG METHODS FOR WIDE COMPLEX TACHYCARDIAS
A limitation of the ECG methods was their inability to
differentiate pre-excitation SVT from VT. From a thera-
peutic standpoint it is not so vital whether the diagnosis
of preexcitation SVT as VT or SVT is considered cor-
rect, because until one refrains from the administration
of agents that are contraindicated in WCTs of unknown
origin (such as verapamil) it is no matter what is its
exact mechanism. IV adenosine administration is con-
sidered safe in regular, monomorphic WCTs of
unknown origin and might terminate a preexcitation
SVT. IV procainamide is a recommended treatment for
both VT and preexcitation SVT, and it may be also
effective (or at least not harmful) in SVT-A; direct cur-
rent cardioversion can terminate almost all kinds of
WCTs as well.
The vi/vt criterion in the fourth step of the aVR Vere-
ckei algorithm is a bit more complicated than the ﬁrst
three steps of the algorithm. The use of the fourth step
was necessary to establish the diagnosis in approxi-
mately 50% to 60% of cases, which is a limitation of this
ECG method compared with the very simple, one-step
lead II RWPT criterion. As the sample size was not cal-
culated prior to performing the study, our ability to
make any conclusions regarding failure to reject the null
hypothesis is substantially limited by not knowing what
the potential effect size we would have been able to
elucidate.
CONCLUSIONS
The aVR lead Vereckei algorithm had a superior overall
test accuracy, sensitivity, and negative predictive value
for ventricular tachycardia diagnosis and inferior
speciﬁcity and positive predictive value for ventricular
tachycardia diagnosis compared to those of the lead II
R-wave peak time criterion. The incorrect diagnoses
made by the aVR Vereckei algorithm were mainly due to
misdiagnosis of supraventricular tachycardia as ventric-
ular tachycardia, while the majority of incorrect diagno-
ses made by the lead II R-wave peak time criterion were
mostly due to misdiagnosis of ventricular tachycardia as
supraventricular tachycardia, which is the more danger-
ous error. We failed to reproduce the excellent overall
test accuracy, sensitivity, speciﬁcity, and predictive val-
ues reported originally for both electrocardiographic
methods. A post hoc analysis suggests that the two elec-
trocardiographic methods have similar diagnostic value
when applied by inexperienced physicians, and the diag-
nostic value of the aVR Vereckei algorithm is superior in
the hands of experienced physicians.
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